ArticleFrontiers in microbiology2026
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Plant-derived nanovesicles (NVs) have emerged as promising natural nanotherapeutics for metabolic and inflammatory diseases due to their inherent biocompatibility, multi-target potential, and ability to mediate cross-kingdom communication. Postmenopausal osteoporosis (PMOP), a prevalent skeletal disorder driven by estrogen deficiency, is characterized by gut-bone axis dysregulation, chronic inflammation, and excessive oxidative stress-pathological features that demand synergistic multi-target interventions. This study aimed to characterize Methods: PQs were isolated via modified differential centrifugation and characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and high-performance liquid chromatography (HPLC). Their bone-targeting capacity was evaluated via Results: PQs exhibited a typical cup-shaped morphology (mean diameter ~89 nm), negative zeta potential (-42.21 ± 0.12 mV), and stable batch-to-batch naringin content (0.65 ± 0.03 μg/mL). Conclusion:
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.